Sales of Impavido, Rhinase Soothing Nasal Gel and Rhinase Lubricating Mist exceeded $2.5 M for 2016 making it a great start for Profounda as it looks to introduce new products to the market in 2017.
Orphan indication received by Profounda is for the treatment of Acanthamoeba Keratitis, also commonly known as AK usually associated with contact lens wear.
